Revenue

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

The following table presents the Company’s disaggregated revenue by offering type (in thousands):

	Three Months Ended March 31,
	2024				2023
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	615	1.9	%	$	579	1.9	%
Third-Party Payer products	1,872		5.9	%	3,408		11.2	%
Patient Services revenue recognized over time:
Direct rental services	3,572		11.2	%	1,869		6.2	%
Third-Party Payer rental services	10,977		34.3	%	11,020		36.3	%
Total Patient Services accounted for under ASC 606	17,036		53.2	%	16,876		55.6	%
Device Solutions revenue recognized at a point in time:
Products	4,213		13.2	%	3,740		12.3	%
Services	2,409		7.5	%	2,576		8.5	%
Device Solutions revenue recognized over time:
Services	1,969		6.2	%	774		2.5	%
Total Device Solutions accounted for under ASC 606	8,591		26.9	%	7,090		23.3	%
Total Revenue Accounted for under ASC 606	25,627		80.1	%	23,966		78.9	%
Patient Services lease revenue	1,555		4.9	%	1,897		6.2	%
Device Solutions lease revenue	4,813		15.0	%	4,507		14.8	%
Total Revenue accounted for under ASC 842, Leases	6,368		19.9	%	6,404		21.1	%
Total Net Revenue	$	31,995	100.0	%	$	30,370	100.0	%

Contract Balances

(dollars in thousands)	As of March 31, 2024		As of December 31, 2023		$ Change
Accounts receivable, net	$	20,543	$	19,830	$	713
Contract assets	$	1,332	$	1,271	$	61

The change in contract assets during the three months ended March 31, 2024 was mainly due to $2.9 million of revenue recognized for which the payment is subject to conditions other than the passage of time, partially offset by $2.8 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's Condensed Consolidated Balance Sheets.